VBIV logo

VBIV
VBI Vaccines Inc.

24,682
Mkt Cap
$14,341.00
Volume
5,434.00
52W High
$0.0505
52W Low
$0.00
PE Ratio
0.00
VBIV Fundamentals
Price
$0.0005
Prev Close
$0.0005
Open
$0.0005
50D MA
$0.0005
Beta
-21.45
Avg. Volume
51,457.38
P/B
-0.00
Loading...
Loading...
VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601. It also develops an enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on April 9, 1965 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of VBI Vaccines Inc.?
What is the 52-week high for VBI Vaccines Inc.?
What is VBI Vaccines Inc. stock price today?
What was VBI Vaccines Inc. stock price yesterday?
What is the Price-to-Book ratio of VBI Vaccines Inc.?
What is the 50-day moving average of VBI Vaccines Inc.?

Latest VBIV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.